Avid Bioservices Files Definitive Proxy Statement
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Avid Bioservices (CDMO) filed its proxy statement for the annual meeting. Shareholders vote soon.
AI Summary
Avid Bioservices, Inc. (CDMO) filed a DEFA14A on December 30, 2024, related to its annual meeting. The filing is a definitive proxy statement, indicating it's for shareholders to vote on company matters. Avid Bioservices, formerly Peregrine Pharmaceuticals Inc., is a contract development and manufacturing organization in the pharmaceutical preparations sector.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, allowing them to exercise their voting rights on corporate governance and other important decisions.
Risk Assessment
Risk Level: low — This is a routine filing for a definitive proxy statement, not indicating any immediate financial or operational risks.
Key Players & Entities
- Avid Bioservices, Inc. (company) — Registrant
- Peregrine Pharmaceuticals Inc. (company) — Former company name
- Techniclone Corp/DE/ (company) — Former company name
- Techniclone International Corp (company) — Former company name
- 20241230 (date) — Filing date
FAQ
What is the purpose of this DEFA14A filing?
The purpose of this DEFA14A filing is to provide shareholders with a definitive proxy statement for Avid Bioservices, Inc.'s annual meeting, outlining matters on which they will vote.
When was this filing made?
This filing was made on December 30, 2024.
What is Avid Bioservices, Inc.'s primary business?
Avid Bioservices, Inc. operates in the Pharmaceutical Preparations sector, identified by SIC code 2834.
Has Avid Bioservices, Inc. operated under other names?
Yes, Avid Bioservices, Inc. was formerly known as Peregrine Pharmaceuticals Inc., Techniclone Corp/DE/, and Techniclone International Corp.
What is the filing fee status for this document?
No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Stats: 1,552 words · 6 min read · ~5 pages · Grade level 16.3 · Accepted 2024-12-30 09:10:41
Filing Documents
- ef20040745_defa14a.htm (DEFA14A) — 21KB
- 0001140361-24-050538.txt ( ) — 22KB
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This communication contains "forward-looking statements" which include, but are not limited to, all statements that do not relate solely to historical or current facts, such as statements regarding the Company's expectations, intentions or strategies regarding the future, or the completion or effects of the proposed sale of Avid to GHO and Ampersand. In some cases, these statements include words like: "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "objective," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue" and "ongoing," or the negative of these terms, or other comparable terminology intended to identify statements about the future. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The Company's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risks and uncertainties related to: the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction that could delay the consummation of the proposed transaction or cause the parties to abandon the proposed transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into in connection with the proposed transaction; the possibility that the Company's stockholders may not approve the proposed transaction; the risk that the parties to the merger agreement may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; risks related to disruption of management time from ongoing business operations due to the proposed transaction; the risk that any an